100% Quality Guarantee
PhD-Level Technical Support
Key Features

PE Anti-Human CD279/PD-1 Antibody [EH12.2H7] (AGEL2723)

SKU AGEL2723
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FCM
Reactivity Human
Host Species Mouse
Isotype Mouse IgG1, κ
Clone EH12.2H7
Conjugation PE
€113 - €390

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

PE Anti-Human CD279/PD-1 Antibody [EH12.2H7]

The PD-1 Monoclonal Antibody (EH12.2H7) is a cutting-edge research tool developed by Assay Genie for studying the PD-1 protein, a key immune checkpoint receptor involved in regulating immune responses. This monoclonal antibody, rigorously tested and validated for its specificity to human samples, is designed to detect and analyze the PD-1 protein in various cell types. Ideal for Western blot applications, the EH12.2H7 antibody provides researchers with a reliable tool for investigating the role of PD-1 in immunology and cancer research.PD-1, also known as programmed cell death protein 1, is a crucial immune checkpoint receptor that plays a pivotal role in maintaining immune tolerance and preventing excessive immune activation.

Dysregulation of PD-1 signaling has been implicated in various diseases, including cancer and autoimmune disorders, making it a target of significant interest in research and therapeutic development. By understanding the mechanisms underlying PD-1 function, researchers can pave the way for the development of innovative immunotherapies aimed at enhancing or modulating immune responses for improved treatment outcomes.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose